TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $285,000 | -42.9% | 15,000 | 0.0% | 0.18% | -45.9% |
| Q3 2021 | $499,000 | -14.3% | 15,000 | 0.0% | 0.34% | -2.3% |
| Q2 2021 | $582,000 | -19.5% | 15,000 | 0.0% | 0.35% | -18.9% |
| Q1 2021 | $723,000 | -7.3% | 15,000 | 0.0% | 0.43% | -4.5% |
| Q4 2020 | $780,000 | -2.7% | 15,000 | -50.0% | 0.45% | +67.5% |
| Q3 2020 | $802,000 | +174.7% | 30,000 | +100.0% | 0.27% | +52.3% |
| Q2 2020 | $292,000 | +97.3% | 15,000 | 0.0% | 0.18% | +34.4% |
| Q1 2020 | $148,000 | -11.4% | 15,000 | 0.0% | 0.13% | +8.3% |
| Q4 2019 | $167,000 | +98.8% | 15,000 | 0.0% | 0.12% | +116.1% |
| Q3 2019 | $84,000 | -35.4% | 15,000 | 0.0% | 0.06% | -29.1% |
| Q2 2019 | $130,000 | +7.4% | 15,000 | 0.0% | 0.08% | +3.9% |
| Q1 2019 | $121,000 | +95.2% | 15,000 | 0.0% | 0.08% | +28.8% |
| Q4 2018 | $62,000 | -26.2% | 15,000 | 0.0% | 0.06% | +9.3% |
| Q3 2018 | $84,000 | -57.4% | 15,000 | 0.0% | 0.05% | -59.7% |
| Q2 2018 | $197,000 | – | 15,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |